Methadone tied to lower risk for discontinuation versus buprenorphine/naloxone
Receipt of methadone for opioid use disorder is associated with a lower risk for treatment discontinuation compared with buprenorphine/naloxone, according to a study published online Oct. 17 in JAMA.
Facebook Comments
https://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.png00aajahttps://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.pngaaja2024-10-19 12:05:222024-10-19 12:05:22Methadone tied to lower risk for discontinuation versus buprenorphine/naloxone